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Splenic hamartoma, also known as splenoma, splenic 
adenoma, or nodular hyperplasia, is a rare benign splenic 
tumour. It is composed of disordered vascular channels 
with abnormal mixture of red or white splenic pulp. 
Mostly it is asymptomatic and encountered incidentally 
at imaging, surgery, or autopsy. Radiologically, 
hamartomas are almost identical to haemangioma. In 
such circumstances, radiolabeled blood pool imaging 
and radiocolloid scintigraphy help to differentiate the 
two entities. We present a case of asymptomatic splenic 
lesion on hybrid radionuclide imaging with single-photon 
emission computed tomography-computed tomography, 
findings suggestive of hamartoma.
A splenic mass was incidentally discovered in a 27-year-
old man on ultrasound abdomen while investigating for 
deranged liver function tests. CT scan was performed 
which showed well circumscribed, rounded isodense 
splenic lesion [Figure 1] along with a smaller lesion in liver.
The patient was completely asymptomatic. Imaging 
findings raised the possibility of haemangioma though 
not typical; therefore, the patient was referred to the 
department of nuclear medicine for radiolabeled red blood 
cell (Tc-99m RBC) scintigraphy. Tc-99mRBC scan was 
performed using modified in vivo method [Figure 2]. 
Scintigraphic findings did not favour the diagnosis of a 
haemangioma, which typically shows increased blood 
pool activity. Radiocolloid scan was considered for further 
evaluation after intravenous injection of Tc-99m-phytate 
revealing increased uptake within the splenic mass 
[Figure 3], favouring the diagnosis of splenic hamartoma.
Splenic hamartoma is a primary benign solid tumour 
first described by Rokitansky, in 1861.[1] Few cases have 
been described in literature with an incidence of 0.13% 
on autopsy.[2]
Hamartoma is composed of disordered vascular 
channels with abnormal mixture of red or white 
splenic pulp. It is classified into two subtypes; white 
pulp type consists of abnormal lymphoid tissue, and 
red pulp type constitutes abnormal sinuses similar to 
red pulp. Most commonly the tumour is composed of 
both subtypes.[3]
Figure 1: Contrast-enhanced computed tomography scan 
showed an enlarged 6 cm splenic lesion with diffuse, 
homogenous retention of contrast in the venous phase (right)
Figure 2: Tc-99m-labelled red blood cell scan; (a) planar 
static and (b) delayed axial single-photon emission computed 
tomography-computed tomography images showed reduced 
blood pool activity within the enlarged splenic lesion as 
compared to the normal splenic parenchyma
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Importance of imaging lies in the need to differentiate 
them from other benign vascular tumours such as 
haemangioma, and malignant lesions of spleen such as 
lymphoma and metastasis.
Most splenic hamartomas are solid masses which appear 
hyperechoic on conventional ultrasound with or without 
cystic changes. On CT, they appear as isodense or 
hypodense with heterogeneous contrast enhancement 
relative to adjacent normal parenchyma. They appear 
isointense on T1-weighed magnetic resonance images 
and heterogeneously hyperintense in T2-weighed 
images.[4,5]
Detection of reticuloendothelial cells, a typical pathological 
feature of splenic hamartoma, is essential for diagnosis. 
These cells are mainly phagocytic. Tc-99m-labelled 
colloid is readily phagocytosed by reticuloendothelial cells 
showing uptake within the tumour, making this modality 
an important diagnostic tool.
Splenic hamartoma should be kept in the differentials of 
solitary splenic lesions in the absence of any malignancy. 
Imaging features may suggest the diagnosis; however, 
final diagnosis must be confirmed on histology. 
Splenectomy may be considered in symptomatic cases 
with rapid increase in size or hematological disorders. Our 
patient was managed conservatively without any surgical 
intervention and is being closely followed up on imaging.
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Figure 3: Tc-99m-phytate scan; (a) planar static and (b) axial 
single-photon emission computed tomography-computed 
tomography images showed intense focal tracer uptake in the 
enlarged splenic lesion (arrows) relative to the adjacent normal 
splenic parenchyma, making the diagnosis of splenic hamartoma 
most likely
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b
